Fluocinolone Acetonide Topical Solution Usp, 0.01% Drug Interactions
Fluocinolone Acetonide Topical Solution Usp, 0.01% Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Fluocinolone Acetonide Topical Solution Usp, 0.01%. Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Acarbose.
Level 1 evidence
Acenocoumarol
Fluocinolone acetonide may increase the anticoagulant activities of Acenocoumarol.
Level 1 evidence
Albendazole
The metabolism of Albendazole can be increased when combined with Fluocinolone acetonide.
Level 2 evidence
Albuterol
The risk or severity of hypokalemia can be increased when Fluocinolone acetonide is combined with Albuterol.
Level 2 evidence
Alogliptin
The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Alogliptin.
Level 1 evidence
Amikacin
Fluocinolone acetonide may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Amlodipine
The metabolism of Amlodipine can be increased when combined with Fluocinolone acetonide.
Level 1 evidence
Amphotericin B
The risk or severity of hypokalemia can be increased when Fluocinolone acetonide is combined with Amphotericin B.
Level 1 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Fluocinolone acetonide.
Level 2 evidence
Apalutamide
The serum concentration of Fluocinolone acetonide can be decreased when it is combined with Apalutamide.
Level 1 evidence
Aprepitant
The metabolism of Fluocinolone acetonide can be decreased when combined with Aprepitant.
Level 2 evidence
Arformoterol
The risk or severity of hypokalemia can be increased when Fluocinolone acetonide is combined with Arformoterol.
Level 2 evidence
Enter your NPI to unlock 37 major interactions for Fluocinolone Acetonide Topical Solution Usp, 0.01%
Fluocinolone Acetonide Topical Solution Usp, 0.01% has 965 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Fluocinolone Acetonide Topical Solution Usp, 0.01% has 285 major, 265 moderate, and 415 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Fluocinolone Acetonide Topical Solution Usp, 0.01%. Always confirm against the full prescribing information.